7 completed, 2 not yet recruiting, 1 active not recruiting. 6 Phase 2, 2 Phase 3, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Active not recruiting 1, Not yet recruiting 1 |
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Gout Chronic: new trials by email Literature Review of Gout Chronic trials Research Report on Gout Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug-Drug Interaction Study of ABP-671 in Gout Patients ABP-671 plus allopurinol - Gout Chronic, Gout | Phase 1 | Completed | Atom Therapeutics Co., Ltd | 22 | 2026-01-23 | 2026-11-02 |
| Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients AR882 75 mg, XOI Low Dose, XOI High Dose - Gout, Gouty Arthritis | Phase 2 | Active not recruiting | Arthrosi Therapeutics | 15 | 2025-12-03 | 2026-05-15 |
| Developing A Gout Action Plan in Primary Care Setting in Singapore Gout action plan - Gout; Hyperuricemia, Gout Flare | Not applicable | Not yet recruiting | SingHealth Polyclinics | 72 | 2025-08-01 | 2025-07-11 |
| Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In Gout Discontibuation of oral ULT, Maintenance of ULT - Gout Chronic | Phase 2 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 450 | 2025-05-01 | 2025-05-04 |
| Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) AR882 50 mg, AR882 75 mg, Placebo - Gout, Arthritis, Gouty | Phase 3 | Completed | Arthrosi Therapeutics | 866 | 2025-03-11 | 2026-09-28 |
| Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) AR882 50 mg, AR882 75 mg, Placebo - Gout, Arthritis, Gouty | Phase 3 | Completed | Arthrosi Therapeutics | 818 | 2024-06-26 | 2026-10-14 |
| Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout AR882 Dose 1, AR882 Dose 2, Allopurinol Tablet - Gout, Arthritis, Gouty | Phase 2 | Completed | Arthrosi Therapeutics | 42 | 2022-08-12 | 2025-01-29 |
| Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients AR882 Dose 1, AR882 Dose 2, Placebo - Gout, Arthritis, Gouty | Phase 2 | Completed | Arthrosi Therapeutics | 140 | 2021-11-16 | 2023-05-12 |
| REduCing Immunogenicity to PegloticasE (RECIPE) Study Pegloticase 8 MG/ML [Krystexxa], MMF, Placebo - Gout Chronic | Phase 2 | Completed | University of Alabama at Birmingham | 35 | 2018-06-14 | 2022-03-16 |
| Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid SEL-212, SEL-037, SVP-rapamycin (SEL-110) - Gout Chronic, Hyperuricemia | Phase 2 | Completed | Selecta Biosciences, Inc. | 152 | 2016-10-01 | 2022-02-14 |
Gout (7) · Hyperuricemia (7) · Arthritis, Gouty (5)
Arthritis (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Crystal Arthropathies (7) · Genetic Diseases, Inborn (7) · Joint Diseases (7) · Metabolic Diseases (7) · Metabolism, Inborn Errors (7) · Musculoskeletal Diseases (7) · Nutritional and Metabolic Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Purine-Pyrimidine Metabolism, Inborn Errors (7) · Rheumatic Diseases (7)
Allopurinol (2) · Pegloticase (1)
Arthrosi Therapeutics (5) · Assistance Publique - Hôpitaux de Paris (1) · Atom Therapeutics Co., Ltd (1) · Selecta Biosciences, Inc. (1) · SingHealth Polyclinics (1) · University of Alabama at Birmingham (1)
United States (8) · Taiwan (3) · Australia (2) · New Zealand (2) · Hong Kong (1) · Singapore (1)
Robert Keenan, MD (3) · R Keenan, MD (2) · Kenneth G Saag, MD (1)
PMID 12535399, PMID 12867348, PMID 22172492, PMID 22995041, PMID 24393558, PMID 26903390, PMID 27457514, PMID 27477556, PMID 27713240, PMID 29643150, PMID 30485934, PMID 30601717, PMID 31151457, PMID 31758246, PMID 32391934, PMID 32541923, PMID 32554059, PMID 32816816, PMID 33618661, PMID 33750034, PMID 34514294, PMID 34882311, PMID 36607199, PMID 37069364, PMID 37285198, PMID 37746085, PMID 38213387, PMID 38239283